PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 185 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $684,000 | +4.0% | 14,328 | -0.8% | 0.00% | 0.0% |
| Q1 2017 | $658,000 | +69.6% | 14,437 | +19.8% | 0.00% | +100.0% |
| Q4 2016 | $388,000 | -6.5% | 12,052 | -0.7% | 0.00% | -33.3% |
| Q3 2016 | $415,000 | -35.8% | 12,143 | -36.7% | 0.00% | -25.0% |
| Q2 2016 | $646,000 | +113.2% | 19,180 | +234.6% | 0.00% | +100.0% |
| Q1 2016 | $303,000 | -79.2% | 5,732 | -72.5% | 0.00% | -60.0% |
| Q1 2014 | $1,458,000 | – | 20,850 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |